Click here to view in chapters format
Agenda
| 00:00:00 | Opening Remarks Dr. Subodh Verma |
| 00.02:10 | HARMONY Outcomes Trial Dr. Lawrence Leiter |
| 00.14:55 | CompoSIT Clinical Trial Program Dr. Lawrence Leiter |
| 00.25:35 | CAMELLIA-TIMI 61 Trial Dr. Lawrence Leiter |
| 00.35:33 | CARMELINA Trial Dr. Subodh Verma |
| 00.49:53 | Management of hyperglycemia Dr. John Buse in in type 2 Diabetes: ADA-EASD Consensus Report 2018 |
| 01:01:17 | Closing Remarks Dr. Subodh Verma |
Faculty
Subodh Verma
MD, PhD, FRCSC, FAHA
Cardiac Surgeon, St. Michael’s Hospital
Professor of Surgery and Pharmacology & Toxicology,
University of Toronto
Canada Research Chair in Cardiovascular Surgery
Toronto, ON
Lawrence A. Leiter
MD, FRCPC, FACP, FACE, FAHA, FACC
Endocrinologist,
St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences,
University of Toronto,
Toronto, ON
John B. Buse
MD, PhD
Verne S. Caviness
Distinguished Professor
Chief, Division of Endocrinology
Director, Diabetes Center
Director, NC Translational and Clinical Sciences Institute
University of North Carolina School of Medicine
Chapel Hill, NC
This program has received an educational grant from Merck Canada Inc.
Video Information
- Credit:No Credit Available
- Post Date:October 31, 2018
- Expiry Date:N/A
